Research

Kea Labs drives process chemistry, biotechnology, NDDS, and AI discovery.

The R&D organization is divided across Hyderabad for process chemistry and Bangalore for biotech, AI modeling, and novel drug delivery systems.

Kea Labs

Research programs across two major hubs

Hyderabad focuses on API chemistry and green chemistry, while Bangalore focuses on biosimilars, AI-assisted modeling, and future medicine.

Hyderabad Process Chemistry

Cost reduction, process optimization, impurity control, and green chemistry.

Bangalore Biotech Hub

Novel drug delivery systems, biosimilars, peptides, and gene therapy vectors.

AI-assisted Discovery

Molecular modeling designed to shorten development cycles from five years to three years.

Clinical Data Management

Clinical trial data coordination and evidence-support workflows.

Biologic Platforms

Recombinant insulin and trastuzumab biosimilar portfolio programs.

Collaborations

Strategic collaborations with global research institutes.